硫酸茚地那韦胶囊人体生物等效性研究

申屠建中;卢晓阳;周惠丽;郑国刚;陈志根;黄明珠;史美甫

中国药学杂志 ›› 2006, Vol. 41 ›› Issue (02) : 126-128.

中国药学杂志 ›› 2006, Vol. 41 ›› Issue (02) : 126-128.
论著

硫酸茚地那韦胶囊人体生物等效性研究

  • 申屠建中;卢晓阳;周惠丽;郑国刚;陈志根;黄明珠;史美甫
作者信息 +

Studies on Bioequivalence of Indinavir Capsule in Healthy Volunteers

  • SHENG-TU Jian-zhong1,LU Xiao-yang1*,ZHOU Hui-li2,ZHENG Guo-gang2,CHEN Zhi-gen1,HUANG Ming-zhu1,SHI Mei-fu1
Author information +
文章历史 +

摘要

目的评价国产茚地那韦胶囊与已上市的进口茚地那韦胶囊的人体生物等效性。方法 18名男性健康志愿者随机交叉po茚地那韦受试制剂和参比制剂各800 mg,采用液相色谱-质谱法测定血清药物浓度。结果茚地那韦参比制剂及受试制剂的tmax分别为(0.61±0.22)和(0.60±0.19)h,ρmax分别为(15.66±4.24)和(15.99±4.29)mg·L-1,AUC0~10h分别为(34.25± 8.95)和(33.40±7.56)mg·h·L-1,t1/2(ke)分别为(1.35±0.34)和(1.32±0.39)h,国产茚地那韦胶囊相对生物利用度为(98.81± 12.05)%。结论方差分析和双单侧t检验结果表明,2种制剂生物等效。

Abstract

OBJECTIVE To evaluate the bioequivalence of domestic and imported indinavir capsule in the healthy volunteers. METHODS A single oral dose of 800 mg test or reference preparations of indinavir was given to 18 healthy volunteers in a randomized crossover study. The indinavir serum concentrations were determined by HPLC-MS assay.RESULTS The main pharmacokinetic parameters of the two products were as follow: tmax(0.61±0.22)and(0.60±0.19)h;ρmax(15.66±4.24)and(15.99±4.29)mg·L-1; AUC0~10(34.25±8.95)and (33.40±7.56)mg·h·L-1;t1/2(ke)(1.35±0.34) and(1.32±0.39)h,respectively.The relative bioavailability of the test to reference capsule was (98.81±12.05) % .CONCLUSION The variance analysis and two one-side t test show that the two formulations are bioe-quivalent.

关键词

茚地那韦 / 生物等效性 / 高效液相色谱-质谱

Key words

indinavir / bioequivalence / HPLC-MS/MS

引用本文

导出引用
申屠建中;卢晓阳;周惠丽;郑国刚;陈志根;黄明珠;史美甫. 硫酸茚地那韦胶囊人体生物等效性研究[J]. 中国药学杂志, 2006, 41(02): 126-128
SHENG-TU Jin-zhong;LU Xio-yng;ZHOU Hui-li;ZHENG Guo-gng;CHEN Zhi-gen;HUNG Ming-zhu;SHI Mei-fu. Studies on Bioequivalence of Indinavir Capsule in Healthy Volunteers [J]. Chinese Pharmaceutical Journal, 2006, 41(02): 126-128

参考文献

[1] ZENG J E. Biomedicine Analyse(生物药物分析)[M] .2nd ed. Beijing:Beijing medical university/Peking union medical college of China united press.1998:230. [2] REMMEL R P, KAWLE S P, WEJLLER D,et al. Simultaneous HPLC assay for quantification of indinavir, nelfinavir, ritonavir,and saquinavir in human plasma[J] .Clin Chem,2000,46(1):73. [3] ZHONG L, YEH K C. Determination of indinavir in human cerebrospinal fluid and plasma by solid-phase extraction and high-performance liquid chromatography with column switching[J] .J Chromatogr B Biomed Sci Appl,1999,734(1):63. [4] YEH K C,DEUTSCH P J,HADDIX H,et al. Single-dose pharmacokinetics of indinavir and the effect of food[J] .Antimicrob Agents Chemother,1998,42(2):332. [5] HSU A,GRANNEMAN G R,CAO G,et al. Pharmacokinetic interaction between ritonavir and indinavir in healthy volunteers[J] .Antimicrob Agents Chemother,1998, 42(11):2784. [6] BENET L Z,CUMMINS C L,WU C Y.Unmasking the dynamic interplay between efflux transporters and metabolic enzymes[J] .Int J Pharm,2004,277(1-2):3.

29

Accesses

0

Citation

Detail

段落导航
相关文章

/